Home » Stocks » IMGO

Imago BioSciences, Inc. (IMGO)

Stock Price: $16.05 USD 0.05 (0.31%)
Updated Jul 27, 2021 4:00 PM EDT - Market closed
Market Cap 516.79M
Revenue (ttm) n/a
Net Income (ttm) -20.70M
Shares Out 32.20M
EPS (ttm) -0.64
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 27
Last Price $16.05
Previous Close $16.00
Change ($) 0.05
Change (%) 0.31%
Day's Open 15.75
Day's Range 15.24 - 16.57
Day's Volume 41,926
52-Week Range 14.99 - 17.95

News

Hide News

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $IMGO #ImagoBioSciences--Imago BioSciences, Inc. Announces Closing of $134.4 Million Initial Public Offering

1 week ago - Business Wire

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $IMGO #IMGO--Imago BioSciences, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock

1 week ago - Business Wire

Imago BioSciences, Inc. has filed to go public with an IPO on the NASDAQ.

1 month ago - SEC

About IMGO

Imago BioSciences is a clinical-stage biopharmaceutical company discovering and developing internally-discovered novel inhibitors and degraders of LSD1, an enzyme that plays a central role in the production of blood cells in the bone marrow, to improve the quality of life of patients with cancer and bone marrow diseases, in addition to prolonging their lives. Our lead product candidate is bomedemstat for the treatment of certain myeloproliferative neoplasms, or MPNs, a family of related, chronic cancers of the bone marrow. The three most common... [Read more...]

Industry
Pharmaceutical Preparations
IPO Date
Jul 16, 2021
CEO
Hugh Y. Rienhoff, Jr., M.D.
Employees
17
Stock Exchange
NASDAQ
Ticker Symbol
IMGO
Full Company Profile

Financial Performance

Financial Statements